UK's SkinBioTherapeutics falls after delaying results amid investigation

Skinbiotherapeutics

20/03/2026 12:02

** Shares of British skin-health company SkinBioTherapeutics SBTX.L down 32.3% at 6.5 pence
** Co announces delay of HY26 results until board investigation into former CEO is completed

** Co says shares expected to be suspended from April 1 until results are published

** Up to Thursday's close, stock had fallen 39.05% this year

 (Reporting by Simone Lobo in Bengaluru)

 ((Simone.Lobo@thomsonreuters.com, +919920570373))